2004N-0330 - Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC12
  



  

  

  



  

  
Submitter : 
  

  
Dr. Carol Tamminga
  

  
Date & Time: 
  

  
08/30/2004 02:08:35
  



  

  
Organization : 
  

  
American College of Neuropsychopharmacology
  



  

  
Health Care Association
  


  

  
Category : 
  


  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 ACNP COMMENTS ON SSRI USE IN ADOLESCENTS



Depression in youth is a serious disorder. It affects school, family and peer relationships, can lead to drug/alcohol abuse and suicide, and is recurrent, often leading to adult depression. Furthermore, depression itself impacts the developing brain. Allowing depression to go untreated significantly delays improvement, thereby increasing the likelihood of long-term negative outcomes.

  

(Full Comments Attached)